Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA-directed RNA polymerase (RNAP) in bacteria is a multisubunit enzyme responsible for transcribing DNA into RNA, using ribonucleoside triphosphates as substrates. It is the central enzyme of gene expression in prokaryotes and is essential for synthesizing all types of cellular RNAs, including mRNA, tRNA, and rRNA. The core enzyme consists of five subunits: two alpha (α), one beta (β), one beta prime (β′), and one omega (ω). The core enzyme associates with a sigma factor (σ) to form the holoenzyme complex (α₂ββ′ωσ) for promoter recognition and initiation. It is a validated target for antibiotics; drugs like rifampicin inhibit its function.
Inhibition of RNA polymerase by binding to the β-subunit and blocking transcription initiation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA-directed RNA Polymerase (Bacterial) (RNAP).